共 50 条
- [1] Cost-effectiveness analysis of branded and authorized generic celecoxib for patients with chronic pain in Japan [J]. PLOS ONE, 2021, 16 (07):
- [2] A Cost-Effectiveness Analysis Of Pregabalin For The Treatment Of Patients With Chronic Cervical Pain With A Neuropathic Component In Japan [J]. JOURNAL OF PAIN RESEARCH, 2019, 12 : 2785 - 2796
- [5] Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2015, 7 : 505 - 520
- [8] Cost-effectiveness analysis of chronic mechanical back pain treatment modalities [J]. TURKISH JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION, 2020, 66 (04): : 413 - 422
- [9] Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain [J]. CLINICAL JOURNAL OF PAIN, 2002, 18 (06): : 355 - 365
- [10] A cost-effectiveness analysis of lusutrombopag for thrombocytopenia in patients with chronic liver disease in Japan [J]. JGH OPEN, 2021, 5 (08): : 879 - 887